- Home
- SGMT vs LNKB Comparison
SGMT vs LNKB Comparison
Compare SGMT & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- LNKB
- Stock Information
- Founded
- SGMT 2006
- LNKB 2018
- Country
- SGMT United States
- LNKB United States
- Employees
- SGMT N/A
- LNKB N/A
- Industry
- SGMT
- LNKB
- Sector
- SGMT
- LNKB
- Exchange
- SGMT Nasdaq
- LNKB Nasdaq
- Market Cap
- SGMT 238.7M
- LNKB 261.4M
- IPO Year
- SGMT 2023
- LNKB N/A
- Fundamental
- Price
- SGMT $8.52
- LNKB $7.03
- Analyst Decision
- SGMT Strong Buy
- LNKB Strong Buy
- Analyst Count
- SGMT 8
- LNKB 1
- Target Price
- SGMT $26.88
- LNKB $9.00
- AVG Volume (30 Days)
- SGMT 655.0K
- LNKB 110.8K
- Earning Date
- SGMT 11-13-2025
- LNKB 10-27-2025
- Dividend Yield
- SGMT N/A
- LNKB 4.30%
- EPS Growth
- SGMT N/A
- LNKB 512.12
- EPS
- SGMT N/A
- LNKB 1.03
- Revenue
- SGMT N/A
- LNKB $122,594,000.00
- Revenue This Year
- SGMT N/A
- LNKB $18.26
- Revenue Next Year
- SGMT N/A
- LNKB N/A
- P/E Ratio
- SGMT N/A
- LNKB $6.84
- Revenue Growth
- SGMT N/A
- LNKB 42.32
- 52 Week Low
- SGMT $1.73
- LNKB $6.09
- 52 Week High
- SGMT $11.41
- LNKB $7.98
- Technical
- Relative Strength Index (RSI)
- SGMT 57.50
- LNKB 48.65
- Support Level
- SGMT $8.05
- LNKB $6.85
- Resistance Level
- SGMT $9.46
- LNKB $7.10
- Average True Range (ATR)
- SGMT 0.65
- LNKB 0.20
- MACD
- SGMT 0.07
- LNKB 0.00
- Stochastic Oscillator
- SGMT 59.31
- LNKB 33.96
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.